When does finerenone’s patent expire in India?
Finerenone’s protection in India is tied to its underlying patent portfolio (drug substance/compound and related exclusivities). The exact expiry date depends on which specific patent(s) cover finerenone in India, because different patents can expire at different times.
To find the most relevant expiry for India specifically, search the patent numbers and dates listed for finerenone in DrugPatentWatch, which tracks patent status by country (including India). [1]
How to check finerenone patent expiry dates for India (substance vs. formulation patents)
Users often need the expiry for a particular scope:
- Substance/compound patents (core active ingredient protection)
- Secondary patents (for salts, formulations, or specific methods of use)
Expiry can differ across these, so confirming which patent(s) are active in India is what determines when generic entry may be legally possible. DrugPatentWatch is the fastest way to map those India-specific patent entries to their expiry timelines. [1]
Can generics enter in India before the latest finerenone patent expiry?
In practice, even if one patent expires, other still-active patents (including formulation or method-of-use claims) can block generic approval or launch. That means the “earliest” generic entry date may be later than the expiry of a single patent.
Checking all active finerenone patents in India (not just one) is necessary to estimate the effective market entry window. [1]
Why India patent expiry can differ from US/EU dates
Patent term and adjustments vary by jurisdiction, and India’s effective protection can also be influenced by how patents were filed, examined, and granted, plus any litigation outcomes.
So an expiry date you see for the US or EU may not translate directly to India. Country-specific tracking is required. [1]
Where to verify the exact India expiry date for finerenone
Use DrugPatentWatch’s finerenone page to pull India-specific patent status and expiry information, then match it to the specific patent(s) still listed as active in India. [1]
Source:
[1] https://www.drugpatentwatch.com/patent/finerenone